Status:
COMPLETED
Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
Lead Sponsor:
International Vaccine Institute
Collaborating Sponsors:
National Institute of Cholera and Enteric Diseases, India
Wellcome Trust
Conditions:
Typhoid
Paratyphoid Fever
Eligibility:
All Genders
2+ years
Phase:
PHASE4
Brief Summary
This study is part of the International Vaccine Institute's (IVI's) typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The ...
Detailed Description
Typhoid fever is a major cause of morbidity worldwide. The disease predominantly affects school-aged children, is more prevalent in urban areas, may last for several weeks and can lead to serious comp...
Eligibility Criteria
Inclusion
- Registered in the project census
- Age \>=2 years
- Provide informed consent to receive vaccine
Exclusion
- Fever (\>37.5 degrees Celsius)
- Pregnancy
- Lactating
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
37673 Patients enrolled
Trial Details
Trial ID
NCT00125008
Start Date
May 1 2003
End Date
January 1 2008
Last Update
August 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Cholera and Enteric Diseases
Kolkata, West Bengal, India